创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

都业弘, 陈秋梅, 吴相华. 炔基膦金(Ⅰ)配合物抗肿瘤活性研究进展[J]. 药学进展, 2023, 47(2): 135-144. DOI: 10.20053/j.issn1001-5094.2023.02.008
引用本文: 都业弘, 陈秋梅, 吴相华. 炔基膦金(Ⅰ)配合物抗肿瘤活性研究进展[J]. 药学进展, 2023, 47(2): 135-144. DOI: 10.20053/j.issn1001-5094.2023.02.008
DOU Yehong, CHEN Qiumei, WU Xianghua. Progress of Research on Biological Activities of Alkynylphosphine Gold(I) Complexes[J]. Progress in Pharmaceutical Sciences, 2023, 47(2): 135-144. DOI: 10.20053/j.issn1001-5094.2023.02.008
Citation: DOU Yehong, CHEN Qiumei, WU Xianghua. Progress of Research on Biological Activities of Alkynylphosphine Gold(I) Complexes[J]. Progress in Pharmaceutical Sciences, 2023, 47(2): 135-144. DOI: 10.20053/j.issn1001-5094.2023.02.008

炔基膦金(Ⅰ)配合物抗肿瘤活性研究进展

Progress of Research on Biological Activities of Alkynylphosphine Gold(I) Complexes

  • 摘要: 顺铂抗肿瘤活性的发现促使人们寻找新的金属配合物作为潜在的抗癌药物,其中金配合物作为抗癌药物的研究受到广泛关注。炔基膦金(Ⅰ)配合物引起的明显抗增殖作用源于其新的作用机制,同时由于其独特的化学性质和相关的配位方式,炔基膦金(Ⅰ)配合物作为未来以金为基础的抗癌药物成为该领域研究的热点之一。综述近年来炔基膦金(Ⅰ)配合物的抗肿瘤活性研究进展,包括炔基膦金(Ⅰ)配合物的结构特点、优化设计、协同药效和诊疗活性等,以期为相关研究和应用提供参考。

     

    Abstract: The discovery of antitumor activity of cisplatin has prompted the search for new metallic complexes as potential anticancer drugs. Among them, gold complexes have gained increasing attention as anticancer drugs. The obvious antiproliferative effect caused by alkynylphosphine gold(Ⅰ) complex stems from its novel mechanism of action. At the same time, alkynylphosphine gold(Ⅰ) complex has become one of the hot spots in the field of gold-based anticancer drugs for the future due to its unique chemical properties and related coordination modes. This review summarizes the research progress of antitumor activity of alkynylphosphine gold(Ⅰ) complexes in recent years, including the structural characteristics, optimal design, synergistic efficacy, diagnostic and therapeutic activity, in the hope of providing reference for related research and application.

     

/

返回文章
返回